Reissue of PA See Section III. Additional Information on Eligibility. The purpose of this funding opportunity announcement FOA is to encourage behavioral intervention development research. Research of interest includes but is not limited to Stage I research, including: 1 drug abuse treatment interventions, including interventions for patients with comorbidities; 2 drug abuse treatment and adherence interventions; 3 drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; 4 interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; 5 interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and 6 interventions to treat substance misuse and chronic pain. July 23, ; March 23, ; July 23, ; March 23, , July 23, , March 23, , by PM local time of applicant organization.
Partner abuse PA affects approximately , pregnant women annually. Pregnant women who experience PA are at high risk for adverse postpartum outcomes that include homicide, high utilization of medical care as well as physical and psychological difficulties. The mental health outcomes of PA, that is posttraumatic stress disorder PTSD and depression, transform the postpartum period from an already challenging process into a potentially overwhelming one, which may threaten the well-being of the mother, infant, and her other children. Furthermore, these emotional difficulties may compromise a woman's ability to access the necessary support and resources to increase safety for herself and her children. Unfortunately, virtually no interventions that aim to decrease the impact of PA on the mental health of perinatal women have been developed or systematically tested.
R34 Planning Grant. See Section III. Additional Information on Eligibility. This Funding Opportunity Announcement FOA solicits applications for planning and initial development of a large scale multi-site research study to prospectively examine human brain, cognitive, behavioral, social, and emotional development beginning prenatally through childhood e. In addition to planning and testing the feasibility of study designs, awardees will be expected to participate in grantee meetings to share lessons learned and to begin to form collaborations needed to establish the network of sites that will conduct this study. This FOA should be used for applications that are not collaborative between sites. Applications requiring two or more collaborating sites to complete the proposed research should apply as a linked set of collaborative R34 applications to the companion collaborative R34 FOA RFA-DA
There are at present no evidence-based interventions for marijuana use during pregnancy, despite its being by far the most commonly used illicit drug during pregnancy particularly among African-American women , and despite growing evidence that it may have a range of long-term cognitive and neurobehavioral consequences e. Further, as with other substances of abuse, the majority of persons needing treatment for marijuana use disorder neither receive nor want it SAMHSA, Universal screening and brief intervention in primary care settings, which has shown significant promise with alcohol and tobacco use, has thus been recommended for further investigation with respect to marijuana use in pregnancy Minnes, et al. However, implementation of brief interventions in medical settings has been limited by a range of substantial obstacles such as lack of time and willingness among providers, and difficulty maintaining adherence to key brief intervention principles. In contrast, technology-delivered brief interventions can be completed during normal wait times without staff involvement, are perfectly replicable, facilitate disclosure, and are relatively inexpensive to deploy. They have therefore received considerable attention as a possible way to address unhealthy substance use in primary care settings, with promising evidence of their efficacy in systematic reviews Riper, et al. This R34 clinical trial planning grant therefore proposes the development and preliminary validation of two high- reach and mutually compatible technology-based interventions for marijuana use during pregnancy. The first, a theory-based, synchronous, and highly interactive computer-delivered brief intervention, will be based on an emerging knowledge base regarding key elements of efficacious technology-delivered interventions. The second intervention, a series of tailored text messages, will build on the rich literature regardin key tailoring elements.
